Photo for Headline Surfer / Orlando Police Officer Samantha Ross is shown with her boss, Orlando Police Chief Eric Smith, who recognized her as the Orlando Police Department's Patrol Officer of the Month for May.
ORLANDO, Fla. -- Orlando police officer Samantha Ross has been named Patrol Officer of the Month for May.
"Officer Ross is known for her adaptability and dedication, consistently stepping up in the Parramore area with an exceptional work ethic," the Orlando Police Department wrote in a social media post congratulating her for being named its patrol officer for May.
Since November 2024, she has made over 140 self-initiated proactive contacts and 16 arrests, including follow-up investigations, narcotics violations, proactive stops, and calls for service.
In May, Officer Ross conducted a proactive traffic stop that led to the seizure of a trafficking amount of MDMA and ultimately resulted in an arrest warrant. She was also instrumental in the arrest of a suspect involved in a battery and attempted rape case.
Since November 2024, she has made over 140 self-initiated proactive contacts and 16 arrests, including follow-up investigations, narcotics violations, proactive stops, and calls for service.
In May, Officer Ross conducted a proactive traffic stop that led to the seizure of a trafficking amount of MDMA and ultimately resulted in an arrest warrant. She was also instrumental in the arrest of a suspect involved in a battery and attempted rape case.
The OPD wrote: "Congratulations, Officer Ross, and thank you for your outstanding service!"
Did You Know?
MDMA, also known as ecstasy or Molly, is primarily being researched for its potential use in treating post-traumatic stress disorder (PTSD). It's being explored in psychotherapy, where it's used alongside therapy sessions. There's also an investigation into its potential in treating social anxiety in autism spectrum disorder, major depressive disorder, and alcohol use disorder.
MDMA is not a medication approved for general use or a standard treatment for any condition outside research settings. Its use in psychotherapy is still experimental, with ongoing clinical trials.
About the Byline Writer: